News
This study highlights lumican as a promising biomarker for predicting the onset and progression of diabetic nephropathy and ...
New Analyses of PSC Data from Phase 2 SPRING Trial Show that Treatment with Nebokitug Is Associated with Dose-Dependent and Significant Improvements in Multiple Inflammatory and Fibrotic Biomarkers Fu ...
3h
Stockhead on MSNAroa lifts after second consecutive quarter of positive cashflowsZealand-based soft-tissue repair company Aroa Biosurgery’s share price made gains after reporting its second consecutive ...
Scientists reveal the genetic secret behind the thick lips of African cichlids, linked to parallel evolution and proteins.
8d
News-Medical.Net on MSNNew therapeutic frontiers in the management of achondroplasiaA recent publication in Genes & Diseases has delivered a compelling synthesis of the latest insights into the cellular ...
Organogenesis Holdings Inc.’s ORGO share price has dipped by 5.30%, which has investors questioning if this is right time to buy.
4h
Sportschosun on MSNCha Hospital enters Japan for the first time in Korea's fertility center...First treatment of stem cells in infertilityCha Medical University Cha Hospital entered Japan for the first time as a domestic infertility center by incorporating the ...
Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, a once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated steatohepatitis ...
Evidence-based, peer-reviewed studies have shown that a single dose of HA after a procedure accelerates tissue healing, ...
QKS Group, a global leader in strategic innovation advisory, today launched its Most Valuable Pioneers (MVP) initiative, a first-of-its-kind program celebrating organizations that are reshaping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results